SHARMILA LILLAND: Open Payments
NPI 1114571098 · VALRICO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 21 payments from 9 companies in 2025. Trend: 2023 $876 · 2024 $1,979 · 2025 $1,831
Long term medical supply or device loan: $1,064Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $1,064 |
| Amgen Inc. | 2 | $248 |
| Syndax Pharmaceuticals, Inc. | 1 | $149 |
| SERVIER PHARMACEUTICALS LLC | 1 | $122 |
| Lilly USA, LLC | 1 | $105 |
| Acrotech Biopharma Inc. | 1 | $64 |
| Janssen Biotech, Inc. | 2 | $42 |
| GENZYME CORPORATION | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: KISQALI, BLINCYTO, BELEODAQ, TREMFYA, SARCLISA, VENCLEXTA.
Industry payments across FL — which companies pay providers there.
